Stocks and Investing Stocks and Investing
Wed, October 3, 2018
Tue, October 2, 2018
Mon, October 1, 2018
Fri, September 28, 2018
Thu, September 27, 2018
Wed, September 26, 2018
Tue, September 25, 2018
Mon, September 24, 2018
Fri, September 21, 2018

Derek Archila Maintained (VNDA) at Buy with Increased Target to $29 on, Sep 21st, 2018


Published on 2024-10-26 08:53:22 - WOPRAI
  Print publication without navigation


Derek Archila of Oppenheimer, Maintained "Vanda Pharmaceuticals Inc." (VNDA) at Buy with Increased Target from $27 to $29 on, Sep 21st, 2018.

Derek has made no other calls on VNDA in the last 4 months.



There are 2 other peers that have a rating on VNDA. Out of the 2 peers that are also analyzing VNDA, 1 agrees with Derek's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Charles Duncan of "Cantor Fitzgerald" Initiated at Hold and Held Target at $26 on, Thursday, August 23rd, 2018


This is the rating of the analyst that currently disagrees with Derek


  • Joel Beatty of "Citigroup" Initiated at Strong Buy on, Wednesday, May 23rd, 2018